Articles tagged "HIV virus"

2015 American Transplant Congress
Donor Selection and Prophylactic IVIg for Induction Immunosuppression Improves Outcomes for HIV+ Kidney Transplant Recipients (HIV+ Tx)
G. Malat,^1,2 L. Panarey,³ A. Sharma,³ K. Ranganna,³ D. Reich,² G. Xiao,² A. Doyle.³
¹Dept of Pharmacy, Hahnemann University Hospital, Philadelphia; ²Dept of Surgery, Drexel University College of Medicine, Philadelphia; ³Dept of Medicine, Drexel University College of Medicine, Philadelphia, PA.
HIV+ Tx recipients are noted to have higher rates of allorecognition through cellular and humoral mediated pathways. Since 2010, our program instituted IVIg use as…
2015 American Transplant Congress
Combined Hepatitic/Cholangiopathic Lesion in HIV-HCV Co-Infected Liver Transplant Recipients Associated With Graft Loss
J. Harbell,¹ A. Doherty,² L. Ferrell,² B. Barin,³ N. Terrault,¹ P. Stock.¹
¹Surgery, University of California, San Francisco, San Francisco, CA; ²Pathology, University of California, San Francisco, San Francisco, CA; ³EMMES Corporation, Rockville, MD.
Background: Co-infection with HIV and viral hepatitis results in poorer outcomes following liver transplantation. In this population, complex immune status, extensive drug regimens, and comorbid…
2015 American Transplant Congress
Estimated Prevalence of HIV in Kidney Transplant Candidates
A. Shaffer, X. Luo, L. Kucirka, A. Cash, A. Massie, C. Durand, D. Segev.
Surgery, Johns Hopkins University, Baltimore, MD.
The passage of the HOPE Act in November 2013 mandated research into HIV+ to HIV+ organ transplantation. To date, the prevalence of HIV in the…
2015 American Transplant Congress
Geographic Differences in HIV+ Kidney Transplant Waitlist Characteristics
J. Locke,¹ S. Gustafson,² C. Durand,³ J. Snyder,² B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ A. Nellore,¹ D. Segev.^2,3
¹University of Alabama, Birmingham, Birmingham, AL; ²SRTR, MMRF, Minneapolis, MN; ³Johns Hopkins University, Baltimore, MD.
Kidney transplant (KT) is now a viable option for select HIV+ end-stage renal disease (ESRD) patients. As OPTN does not collect HIV status at waitlisting,…
2015 American Transplant Congress
Survival Benefit of Liver Transplant Among HIV+ Waitlist Candidates
C. Durand,¹ S. Gustafson,² J. Locke,³ J. Snyder,² B. Shelton,³ R. Reed,³ P. MacLennan,³ S. Mehta,³ A. Nellore,³ D. Segev.^1,2
¹Johns Hopkins University, Baltimore, MD; ²Scientific Registry of Transplant Recipients (SRTR), CDRG, Minneapolis, MN; ³University of Alabama, Birmingham, Birmingham, Al.
Liver failure is the most common cause of non-AIDS related death among HIV+ patients, primarily due to high prevalence of co-infection with hepatitis C (HCV)…